{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:16:57Z","timestamp":1773296217274,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.2146\/ajhp080188","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T19:34:12Z","timestamp":1271878452000},"page":"737-740","source":"Crossref","is-referenced-by-count":5,"title":["Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis"],"prefix":"10.1093","volume":"67","author":[{"suffix":"Jr.","given":"Don","family":"Hayes","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and Internal Medicine, College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"Anstead","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Internal Medicine, College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena T.","family":"Warner","sequence":"additional","affiliation":[{"name":"College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, College of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert O.","family":"Ballard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Kentucky, Lexington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041509084549400_b1-0670737","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ejcts.2004.08.015","article-title":"Long-term outcome of lung transplantation for cystic fibrosis\u2014Danish results","volume":"26","author":"Bech","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"2019041509084549400_b2-0670737","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpainsymman.2007.08.016","article-title":"Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline","volume":"36","author":"Charles","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"2019041509084549400_b3-0670737","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1183\/09031936.97.10102270","article-title":"Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease","volume":"10","author":"Jankelson","year":"1997","journal-title":"Eur Respir J"},{"key":"2019041509084549400_b4-0670737","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#supportive (accessed 2010 Feb 2.)"},{"key":"2019041509084549400_b5-0670737","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0885-3924(93)90131-E","article-title":"Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease","volume":"8","author":"Farncombe","year":"1993","journal-title":"J Pain Symptom Manage"},{"key":"2019041509084549400_b6-0670737","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/026921639400800406","article-title":"The use of nebulized opioids for breathlessness: a chart review","volume":"8","author":"Farncombe","year":"1994","journal-title":"Palliat Med"},{"key":"2019041509084549400_b7-0670737","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0140-6736(93)92113-8","article-title":"Nebulised morphine","volume":"342","author":"Tooms","year":"1993","journal-title":"Lancet"},{"key":"2019041509084549400_b8-0670737","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/104990919701400201","article-title":"Nebulized morphine for paroxysmal cough and dyspnea in a nursing home resident with metastatic cancer","volume":"14","author":"Stein","year":"1997","journal-title":"Am J Hosp Palliat Care"},{"key":"2019041509084549400_b9-0670737","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1345\/aph.1E328","article-title":"Nebulized morphine for relief of dyspnea due to chronic lung disease","volume":"39","author":"Brown","year":"2005","journal-title":"Ann Pharmacother"},{"key":"2019041509084549400_b10-0670737","first-page":"825","article-title":"The perception of breathlessness in asthma","volume":"126","author":"Burdon","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"2019041509084549400_b11-0670737","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thx.51.6.596","article-title":"Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease","volume":"51","author":"Leung","year":"1996","journal-title":"Thorax"},{"key":"2019041509084549400_b12-0670737","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0149-2918(99)80035-6","article-title":"Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation","volume":"21","author":"Kanga","year":"1999","journal-title":"Clin Ther"},{"key":"2019041509084549400_b13-0670737","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.100.2.205","article-title":"End-of-life care in cystic fibrosis","volume":"100","author":"Robinson","year":"1997","journal-title":"Pediatrics"},{"key":"2019041509084549400_b14-0670737","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1099-0496(200009)30:3<257::AID-PPUL10>3.0.CO;2-R","article-title":"Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease","volume":"30","author":"Janahi","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"2019041509084549400_b15-0670737","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000081769","article-title":"Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient","volume":"71","author":"Graff","year":"2004","journal-title":"Respiration"},{"key":"2019041509084549400_b16-0670737","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1542\/peds.110.3.e38","article-title":"Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis","volume":"110","author":"Cohen","year":"2002","journal-title":"Pediatrics"},{"key":"2019041509084549400_b17-0670737","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM198112313052703","article-title":"Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases","volume":"305","author":"Woodcock","year":"1981","journal-title":"N Engl J Med"},{"key":"2019041509084549400_b18-0670737","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0922-4106(94)90195-3","article-title":"Characterization of non-conventional opioid binding sites in rat and human lung","volume":"268","author":"Cabot","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"2019041509084549400_b19-0670737","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(96)00363-9","article-title":"Quantitative autoradiography of peripheral opioid binding sites in rat lung","volume":"310","author":"Cabot","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"2019041509084549400_b20-0670737","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/pupt.1997.0094","article-title":"Morphine has a dual concentration- dependent effect on K(+)-evoked substance P release from rat peripheral airways","volume":"10","author":"Cabot","year":"1997","journal-title":"Pulm Pharmacol Ther"},{"key":"2019041509084549400_b21-0670737","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(93)90927-A","article-title":"Tachykinin-mediated respiratory effects in conscious guinea pigs: modulation by NK1 and NK2 receptor antagonists","volume":"241","author":"Kudlacz","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"2019041509084549400_b22-0670737","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.1996.tb00192.x","article-title":"Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects","volume":"41","author":"Masood","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"2019041509084549400_b23-0670737","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/bja\/61.2.228","article-title":"Absorption and bioavailability of nebulized morphine","volume":"61","author":"Chrubasik","year":"1988","journal-title":"Br J Anaesth"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/9\/737\/28424711\/ajhp0737.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T09:55:46Z","timestamp":1555322146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/9\/737\/5130129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp080188","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,5,1]]},"published":{"date-parts":[[2010,5,1]]}}}